Claire Mazumdar, Chief Executive Officer at Bicara Therapeutics, sold BCAX on Aug 10, 2026
Data as of Oct 27
▼ SELL$280K10,000 shares at $27.98Claire Mazumdar Chief Executive OfficerBCAX Bicara Therapeutics Inc.
- Traded
- Aug 10, 2026
- Disclosed
- Aug 12, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
BCAX since disclosure
−29.0%
after the sale
Similar stocks (XLV) since disclosure
+6.4%
XLV — its sector index fund
Change in closing price from Aug 12, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.